SCHEMBL2822700

SCHEMBL2822700

CCOC(=O)c1ccccc1CN1CCOc2cc(NC(=O)c3nc(Cl)c(CC)[nH]3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.42
MAPT P10636 6/20 0.42
THRB P10828 1/20 0.42
POLB P06746 2/20 0.39
MAPK1 P28482 3/20 0.38
TP53 P04637 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
TOP2A P11388 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GAA P10253 2/20 0.36
TSHR P16473 1/20 0.36
ACR P10323 1/20 0.36
BRD4 O60885 1/20 0.36
ALDH1A1 P00352 2/20 0.36
INSR P06213 1/20 0.36
MET P08581 1/20 0.36
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2822824 0.94 SIRT1 (0.40) MAPTTP53NPC1RAB9ATOP2A
SCHEMBL2822035 0.83 SMN1; SMN2 (0.42) LMNAMAPTPOLBMAPK1TP53
SCHEMBL2823787 0.82 ROCK2 (0.45) MAPTPOLBMAPK1TP53NPC1
SCHEMBL2827072 0.81 TOP2A (0.42) LMNAMAPTPOLBMAPK1TP53
SCHEMBL15501937 0.81 TOP2A (0.40) LMNAMAPTPOLBMAPK1TP53
SCHEMBL2822127 0.80 TOP2A (0.41) LMNAMAPTPOLBTP53NPC1
SCHEMBL2826965 0.78 TOP2A (0.42) LMNAMAPTTHRBPOLBTP53
SCHEMBL2822912 0.76 TOP2A (0.41) LMNAMAPTTHRBTP53NPC1
SCHEMBL2824174 0.75 BRD4 (0.46) LMNAMAPTTHRBTSHRBRD4
SCHEMBL2825218 0.75 L3MBTL1 (0.41) MAPTPOLBTP53NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2226322-B1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO CO LTD (JP) 2015-01-21 EP disclosed
US-8927588-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-01-06 US disclosed
US-20140073622-A1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-03-13 US disclosed
US-8536197-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-09-17 US disclosed
US-20100311966-A1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-12-09 US disclosed
EP-2226322-A1 IMIDAZOLE CARBONYL COMPOUND Daiichi Sankyo Company, Limited (JP) 2010-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311966-A1 IMIDAZOLE CARBONYL COMPOUND TOP1, TOP2B, TOP2A LMNA 948/4885MAPT 1455/4885THRB 3180/4885
US-20140073622-A1 IMIDAZOLE CARBONYL COMPOUND TOP1, TOP2B, TOP2A LMNA 1119/4885MAPT 1979/4885THRB 4199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.